CASI Pharmaceuticals
CASI
CASI
27 hedge funds and large institutions have $2.41M invested in CASI Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less capital invested
Capital invested by funds: $3.33M → $2.41M (-$914K)
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$22K | |
| 2 | +$19K | |
| 3 | +$18.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.64K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$1.99K |
Top Sellers
| 1 | -$61.1K | |
| 2 | -$39K | |
| 3 | -$6.89K | |
| 4 |
WSCM
Wellington Shields Capital Management
New York
|
-$2.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$397 |